AMRN
Price
$19.91
Change
-$0.16 (-0.80%)
Updated
Oct 17, 03:09 PM (EDT)
Capitalization
415.1M
Intraday Buy/Sell Signals
Interact to see
Advertisement

AMRN

Header iconAMRN Comparison
Open Charts AMRNBanner chart's image
Amarin
Price$19.91
Change-$0.16 (-0.80%)
Volume$104
Capitalization415.1M
AMRN Comparison Chart in %
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 93.85B. The market cap for tickers in the group ranges from 72.83K to 734.54B. LLY holds the highest valuation in this group at 734.54B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 20%. MIRA experienced the highest price growth at 34%, while SCLX experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 84%. For the same stocks of the Industry, the average monthly volume growth was 71% and the average quarterly volume growth was 26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 32
P/E Growth Rating: 65
Price Growth Rating: 52
SMR Rating: 100
Profit Risk Rating: 77
Seasonality Score: 0 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (AMRN: $20.07)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green while.

  • AMRN’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 6 TA indicator(s) are bullish.

  • AMRN’s TA Score: 6 bullish, 4 bearish.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +5.24% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.91%. For the same industry, the average monthly price growth was +2.58%, and the average quarterly price growth was +20.27%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.91% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN
Capitalization415M
EBITDA-70.12M
Gain YTD106.907
P/E RatioN/A
Revenue219M
Total Cash299M
Total Debt7.34M
FUNDAMENTALS RATINGS
AMRN: Fundamental Ratings
AMRN
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMRN
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTRIX30.35N/A
N/A
Fidelity Advisor Mega Cap Stock I
IJEAX11.23N/A
N/A
VY® JPMorgan Emerging Markets Equity A
AIVOX11.35N/A
N/A
American Century International Opps A
BVALX14.96N/A
N/A
Brown Advisory BeutelGoodmanLg-CpValInst
WVMIX11.56N/A
N/A
William Blair Mid Cap Value I

AMRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+0.50%
KZR - AMRN
56%
Loosely correlated
-3.02%
CNTB - AMRN
55%
Loosely correlated
-2.14%
HRTX - AMRN
44%
Loosely correlated
-3.70%
MGNX - AMRN
44%
Loosely correlated
+0.30%
ALXO - AMRN
43%
Loosely correlated
-0.60%
More